Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
| ▸ | METAP2 | P50579 | 1/20 | 0.30 |
| ▸ | METAP1 | P53582 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18734969 | 0.88 | — | — | |
| SCHEMBL18735173 | 0.88 | MGAM (0.33) | MGAMGAASIMGAM2 | |
| SCHEMBL18735361 | 0.87 | CYP1A2 (0.40) | MGAMGAASIMGAM2METAP2 | |
| SCHEMBL18734968 | 0.84 | L3MBTL1 (0.36) | MGAMGAASIMGAM2 | |
| SCHEMBL18734953 | 0.81 | MGAM (0.32) | MGAMGAASIMGAM2 | |
| SCHEMBL18734942 | 0.81 | METAP2 (0.30) | METAP2METAP1 | |
| SCHEMBL18735330 | 0.81 | CYP2C9 (0.36) | METAP2METAP1 | |
| SCHEMBL18734954 | 0.81 | — | — | |
| SCHEMBL18734960 | 0.79 | — | — | |
| SCHEMBL18735365 | 0.79 | CYP1A2 (0.35) | METAP2METAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017060400-A1 | PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS | NEUROVIVE PHARMACEUTICAL AB (SE) | 2017-04-13 | — | — | WO | disclosed |